Business Wire

CA Ventures Plans $500 Million Investment in European Housing


Chicago-based CA Ventures today announced plans to invest $500 million over the next five years in the European housing market, specifically across the purpose-built student housing and multifamily apartment sectors.

This press release features multimedia. View the full release here:

ARC at Old Colony (Chicago): CA Ventures transformed an existing office building into a 384-bed stud ...

ARC at Old Colony (Chicago): CA Ventures transformed an existing office building into a 384-bed student housing community serving Illinois’ largest concentration of urban college campuses. (Photo: Business Wire)

A vertically integrated owner, developer and operator of apartments spanning all adult life stages, CA Ventures has a $6.7 billion portfolio comprising student housing, multifamily and senior living communities throughout the United States. Over the last eight years, the firm’s student housing entity, CA Student Living, has amassed a $3 billion portfolio serving over 40 universities in the U.S., Canada, Latin America and, now, Europe. During that same period, CA successfully sold over $2.5 billion of student accommodation assets. The firm’s strategy is to deliver highly amenitized, best-in-class near-campus properties in leading university markets, both nationally and internationally, where enrollments have increased and the housing supply has not kept pace.

“CA has been an innovator in student housing in the Americas for over a decade and, as a team, we’ve been evaluating the European housing market closely for several years,” said Tom Scott, CEO of CA Ventures. “We believe the market for purpose-built student housing in Europe is poised to benefit from growing university enrollments, increasing consumer adoption and a very limited supply of amenitized housing. As we are more than just capital, our capabilities as a vertically integrated developer and operator uniquely position us to bring our successful model to Europe, capitalizing on the scale and depth of these markets.”

The firm is currently developing two student housing projects in Poland – 700 beds in Krakow and 400 beds in Warsaw – and is in active negotiations to acquire properties and development sites in the U.K., the Netherlands, Germany, Spain, Ireland and the Czech Republic.

“As a pioneer of pedestrian-oriented, infill high-rise housing proximate to growing university populations, CA has delivered nearly 20,000 purpose-built student housing beds to date,” said JJ Smith, president of CA Student Living. “We have a strong track record of bringing a market-specific curation of building design, unit mix and amenity offerings to underserved university populations in the U.S. and internationally.”

“Across the geographically diverse markets in which we do business, student preferences are actually quite similar despite cultural nuances,” continued Smith. “Today’s students seek modern designs and conveniences such as fully furnished suites, private bedrooms and bathrooms, ample closet storage and a robust combination of well-appointed common spaces for social and academic pursuits. On-site management ties it all together with hands-on programming and a keen eye for safety protocols.”

According to Smith, Poland is a particularly attractive European market with strong enrollment growth from locals as well as students from other countries due to its high-quality, cross-discipline university programs offered in English. CA estimates that while nearly 50 percent of the 2 million university students in Poland do not live with their parents, there are less than 200,000 student housing beds currently available, much of it functionally obsolete.

“Broadly across Europe, less than a third of all students currently live in purpose-built student housing, so we see tremendous runway,” said Smith. “We have spent a significant amount of time researching specific markets, identifying landowners and pinpointing co-development partners looking to parlay their local expertise to a platform that de-risks their position and provides capital alongside design, development, construction management, leasing and operations expertise in the student accommodations sector. Already we have enjoyed great success and this is just the beginning. Our access to capital and ability to handle all aspects of development will allow us to move quickly to secure the best opportunities.”

About CA Ventures:

CA Ventures LLC is a Chicago-based real estate investment holding company whose international portfolio includes $7.8 billion in assets throughout the U.S., Canada and Latin America. While initially focused on student housing, CA Ventures has since diversified into other sectors, including office, senior living, multifamily, and hospitality. In addition to development and renovation, the firm specializes in institutional joint ventures; value add investing; equity and debt sourcing; and asset management services. CA Ventures serves as the holding company for the CA family of companies, including CA Student Living, CA Office / Vanderbilt Partners, CA Senior Living, CA Residential, CA International, and CA Hospitality. For more information, visit

Contact information

Taylor Johnson
Sara Williams, (312) 267-4510
Abe Tekippe, (312) 267-4528
CA Ventures LLC
JJ Smith, (312) 994-1882

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Seoul Semiconductor’s SunLike Series LEDs Win Product of the Year Award from Elektronik Magazine23.3.2018 18:28Pressemelding

Seoul Semiconductor, a global innovator of LED products and technology, announced on March 23rd that its SunLike Series natural spectrum LED product won the Gold Award at the Elektronik Product of the Year 2018 Awards, hosted by Elektronik (, a leading German electronics publication. This press release features multimedia. View the full release here: Product of the Year Award from Elektronik Magazine (SunLike) (Photo: Business Wire) As a publication specializing in electrical and electronic components, “Elektronik” is a prestigious magazine with an illustrious history and the largest number of subscribers in Germany. Over the past 20 years, they have conducted annual surveys among their subscribers to find the “most creative and innovative products.” Based on these survey results, Elektronik selects the top product that with the most impact in its corresponding field, and confers the awards accordingl

Elliott Welcomes Imminent Bezeq Board Overhaul and New Era for Strong Independent Governance23.3.2018 16:05Pressemelding

Elliott Advisors (UK) Limited (“Elliott”), which advises funds which collectively hold a significant economic interest in Bezeq The Israeli Telecommunication Corporation Ltd. (“Bezeq” or the “Company”), welcomes the proposed governance reforms announced by Bezeq last night. In its initial letter to Bezeq Interim Chairman David Granot, dated January 16, 2018, Elliott outlined the urgent need to address the Company’s serious corporate governance issues, and called for changes at the Board level that result in “the right mixture of expertise, independence and integrity for the future.” Elliott stated then, and reiterates now, its belief that “there is significant value to be unlocked if the right steps are taken to improve its corporate governance.” Bezeq has strong business fundamentals, an exemplary workforce, and great potential. Following yesterday’s announcement, Elliott highlights the changes that have occurred since January 16th. Taken together, these amount to a revolution in the

Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe23.3.2018 12:52Pressemelding

Clovis Oncology, Inc. (NASDAQ:CLVS) today announced the initiation of an early access program in Europe for rucaparib for treatment and as maintenance therapy in recurrent ovarian cancer. The program will be overseen and implemented by Caligor Coghlan, which specializes in early access to medicines. The program, to be known as the Rucaparib Access Program (RAP), will enable participation from certain countries in Europe, where permitted by applicable rules, procedures and regulatory authorities. The RAP protocol allows for rucaparib treatment of an individual patient with third-line or greater BRCA mutant epithelial, fallopian tube, or primary peritoneal ovarian cancer who has platinum-sensitive disease and is unable to tolerate further platinum-based chemotherapy or has platinum-resistant disease and needs treatment with single agent rucaparib. The RAP protocol will also provide access to rucaparib for maintenance therapy of an individual patient with recurrent epithelial ovarian, fal

CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets23.3.2018 12:50Pressemelding

Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the European Union’s (EU) European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a conditional marketing authorization for Rubraca as monotherapy treatment of adult patients with platinum sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with two or more prior lines of platinum based chemotherapy, and who are unable to tolerate further platinum based chemotherapy. The European Marketing Authorization application for the treatment indication was based on objective response rate and duration of response results from two multicenter, single-arm, open-label clinical trials, Study 10 and ARIEL2, in women with advanced BRCA mutant ovarian cancer who had progressed after two or more prior chemotherapies. “The recommendation

Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/rilpivirine)23.3.2018 12:46Pressemelding

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for JULUCA™ (dolutegravir 50mg [ViiV Healthcare UK Ltd]/rilpivirine 25mg [Janssen Sciences Ireland UC]). Dolutegravir/rilpivirine is a single-pill, two-drug regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase strand transfer inhibitor (INSTI).1 “We are delighted to be one step closer to bringing JULUCA™ to people living with HIV in Europe,” said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, LLC. “Building on our 25-year c

Aitheon Executives Educate World Leaders on Benefits, Challenges of AI at the Annual World Government Summit in Dubai23.3.2018 12:00Pressemelding

Aitheon, makers of the world’s first blockchain-powered platform to solve real problems by integrating AI, robotics, IoT, human specialists and cryptocurrency, announced today that executives from the company held a series of high-level briefings with world leaders at the Annual World Government Summit in Dubai. Briefings covered the benefits and challenges of AI, and revolutionary new solutions to world challenges made possible by transformative new technologies. (Read the full release at This press release features multimedia. View the full release here: Aitheon founder and CEO, Andrew Archer, and Chief Strategy Officer, Ryan Burleson, were invited to brief leaders at the Summit by Cyrus Hodes, Co-founder and Director of the AI Initiative, an undertaking of the Future Society at Harvard University’s Kennedy School. Archer and Burleson addressed a variety of AI-related topics, including the impact of AI on